{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:30:31Z","timestamp":1790209831056,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1996,11,1]],"date-time":"1996-11-01T00:00:00Z","timestamp":846806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":8468,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1093\/oxfordjournals.annonc.a010797","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T21:52:32Z","timestamp":1334785952000},"page":"939-944","source":"Crossref","is-referenced-by-count":28,"title":["A phase I study of pentosan polysulfate sodium in patients with advanced malignancies"],"prefix":"10.1016","volume":"7","author":[{"given":"R.M.","family":"Lush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Pluda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Headlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0005","first-page":"559","article-title":"Prevention of post-operative thromboembolic complications: A prospective comparison between dextran 70, dihydroergotamine heparin and sulfated polysaccharide","volume":"146","author":"Bergqvist","year":"1980","journal-title":"Acta Chir Scand"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/bjs.1800680702","article-title":"A comparative study of dextran 70 and a sulfated polysaccharide in the prevention of post-operative thromboembolic complications","volume":"68","author":"Bergqvist","year":"1981","journal-title":"Br J Surg"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archsurg.1976.01360190039006","article-title":"Drug prevention of postoperative deep vein thrombosis: A comparative study of calcium heparinate and sodium pentosan polysulfate","volume":"111","author":"Joffe","year":"1976","journal-title":"Arch Surg"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0049-3848(84)90340-2","article-title":"Identification of heparin cofactor II as the principal plasma co-factor for the antithrombin activity of pentosan polysulfate (SP54)","volume":"36","author":"Scully","year":"1984","journal-title":"Thromb Res"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.ATV.9.2.147","article-title":"Sulfated polysaccharides modulate effects of acidic and basic fibroblast growth factors on repair of injured confluent human vascular endothelium","volume":"9","author":"Klein-Soyer","year":"1989","journal-title":"Arterioscler"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pros.2990200308","article-title":"Effect of pentosan, a novel cancer chemotherapeutic ageant, on prostate cancer cell growth and motility","volume":"20","author":"Pienta","year":"1992","journal-title":"The Prostate"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0035","first-page":"2143","article-title":"Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo","volume":"13","author":"Nguyen","year":"1993","journal-title":"Anticancer Res"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0040","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/jnci\/83.10.716","article-title":"Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate","volume":"83","author":"Wellstein","year":"1991","journal-title":"J Nati Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0045","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1016\/0006-2952(88)90608-9","article-title":"Activity of pentosan polysulphate and derived compounds on vascular endothelial cell proliferation and migration induced by acidic and basic FGF in vitro","volume":"37","author":"Herbert","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0050","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/jnci\/84.22.1716","article-title":"Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals","volume":"84","author":"Zugmaier","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0055","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/jnci\/85.19.1585","article-title":"Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma","volume":"85","author":"Pluda","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0060","first-page":"262","article-title":"The effect of pentosan polysulphate (SP54) on the human fibrinolytic system","volume":"113","author":"Gaffney","year":"1986","journal-title":"Folia Haematol"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0038-1661640","article-title":"Anticoagulant activities of pentosan polysulphate (hemoclar) due to release of hepatic triglyceride lipase (HTGL)","volume":"56","author":"Barrowcliffe","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0049-3848(80)90018-3","article-title":"Anticoagulant activities of a pentosane polysulfate: Comparison with standard heparin and a fraction of low molecular weight heparin","volume":"19","author":"Soria","year":"1980","journal-title":"Thromb Res"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-0038-1661326","article-title":"Metabolism of sodium pentosan polysulfate as measured by a new competitive binding assay for sulfated polysaccharides\u2013comparison with effects upon anticoagulant activity, lipolysis, and plateletgranule protein","volume":"53","author":"MacGregor","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0080","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2141.1985.tb07474.x","article-title":"The importance of thrombin inhibition for the expression of the anticoagulant activity of heparin, dermatan sulfate, low molecular weight heparin, and pentosan polysulfate","volume":"60","author":"Ofosu","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0038-1647027","article-title":"Further studies on the mechanisms for the anti-thrombou'c effects of sulfated polysaccharides in rabbits","volume":"60","author":"Ofosu","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0090","first-page":"77","article-title":"Comparison between heparin and a heparin analogue (sodium pentosan polysulphate) in the initial treatment of deep vein thrombosis","volume":"15","author":"Bergqvist","year":"1986","journal-title":"VASA"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/clpt.1985.154","article-title":"Pentosan polysulfate: The effect on hemostasis of a continuous 3 day infusion","volume":"38","author":"deProst","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0038-1661453","article-title":"Tolerance and biologic activity of pentosan polysulfate after intramuscular or subcutaneous administration for 10 days in human volunteers","volume":"55","author":"Sie","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0038-1657140","article-title":"A comparison of pentosan polysulphate and heparin II: Effects of subcutaneous injection","volume":"47","author":"Fischer","year":"1982","journal-title":"Thromb Haemost"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1749-6632.1993.tb17191.x","article-title":"Heparin-binding growth factor blockade with pentosan polysulfate","volume":"698","author":"Swain","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0049-3848(82)90081-0","article-title":"Influence of heparin of different heparin fractions and of a low molecular weight heparin-like substance on the mechanism of fibrinolysis","volume":"27","author":"Vinazzer","year":"1982","journal-title":"Thromb Res"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0120","first-page":"272","article-title":"Clinical studies on the fibrinolytic effect of pentosan polysulfate","volume":"113","author":"Vinazzer","year":"1986","journal-title":"Folia Haematol, Leipzig (Letter)"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0125","series-title":"Manual of Oncologic Therapeutics","first-page":"445","article-title":"Appendix A; Grading of toxicity","author":"Wittes","year":"1991"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02614221","article-title":"Phase I trial of pentosan polysulfate","volume":"13","author":"Swain","year":"1995","journal-title":"Invest New Drugs"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0049-3848(86)90270-7","article-title":"Pentosane polysulphate associated thrombocytopenia","volume":"42","author":"Follea","year":"1986","journal-title":"Thromb Res"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0140","article-title":"Pentosan induces thrombocytopenia and platelet dysfunction during continuous i.v. infusion","volume":"575","author":"Tannenbaum","year":"1991","journal-title":"Blood"},{"issue":"4","key":"10.1093\/oxfordjournals.annonc.a010797_bb0145","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2141.1994.tb05120.x","article-title":"Pentosan-induced thrombocytopenia: Support for an im complex mechanism","volume":"88","author":"Goad","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0049-3848(87)90449-X","article-title":"Pharmacokinetics of 125I-labeled pentosan polysaccharid polysulfate in the rabbit","volume":"48","author":"Cadroy","year":"1987","journal-title":"Thromb Res"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0155","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/00002030-199112000-00021","article-title":"Pharmacokinetics of intravenous pentosan polysulphate (HOE\/BAY 946) in HIV-positive patients","volume":"5","author":"Peters","year":"1991","journal-title":"AIDS"},{"key":"10.1093\/oxfordjournals.annonc.a010797_bb0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-0038-1661092","article-title":"Metabolism of pentosan polysulfate in man-catabolism of iodinated derivatives","volume":"51","author":"MacGregor","year":"1984","journal-title":"Thromb Haemost"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419608203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419608203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/7\/9\/939\/446877\/7-9-939.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T01:29:50Z","timestamp":1647480590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419608203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["S0923753419608203"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a010797","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}